Not Rated
|
Fund Size
(0.06% of Investment in Category)
|
Expense Ratio
(2.13% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 24-Nov-25 | 10054.20 | 0.54% | - | 1.02% | 192/249 |
| 1 Month | 31-Oct-25 | 10013.20 | 0.13% | - | 0.34% | 128/246 |
| 3 Month | 01-Sep-25 | 10174.80 | 1.75% | - | 4.03% | 190/245 |
| 6 Month | 30-May-25 | 10449.30 | 4.49% | - | 5.64% | 147/234 |
| YTD | 01-Jan-25 | 9741.50 | -2.58% | - | 4.73% | 178/220 |
| Since Inception | 27-Dec-24 | 9837.00 | -1.63% | -1.75% | 12.49% | 208/219 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| No Data Found | |||||
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Divis Laboratories Ltd. | Pharmaceuticals | 296 | 8.81% | 1.06% | 9.27% (Apr 2025) | 0% (Nov 2024) | 43.94 k | 0.00 |
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 257.4 | 7.66% | 0.13% | 8.83% (Apr 2025) | 0% (Nov 2024) | 1.52 L | 0.00 |
| Apollo Hospitals Enterprises Ltd. | Hospital | 210.1 | 6.26% | -0.03% | 6.29% (Aug 2025) | 0% (Nov 2024) | 27.36 k | 0.00 |
| Cipla Ltd. | Pharmaceuticals | 168 | 5.00% | -0.45% | 8.33% (Apr 2025) | 0% (Nov 2024) | 1.12 L | -4.90 k |
| Neuland Laboratories Ltd. | Pharmaceuticals | 137.4 | 4.09% | 0.31% | 4.09% (Oct 2025) | 0% (Nov 2024) | 8.34 k | 0.00 |
| Biocon Ltd. | Pharmaceuticals | 126.4 | 3.76% | 0.17% | 4.24% (Jan 2025) | 0% (Nov 2024) | 3.40 L | 0.00 |
| Fortis Healthcare Ltd. | Hospital | 123 | 3.66% | -0.17% | 3.83% (Sep 2025) | 0% (Nov 2024) | 1.20 L | -7.23 k |
| Aurobindo Pharma Ltd. : Futures Near | Pharmaceuticals | 116.8 | 3.48% | 0.04% | 3.48% (Oct 2025) | 0% (Nov 2024) | 1.02 L | 0.00 |
| Piramal Pharma Ltd. | Pharmaceuticals | 108.9 | 3.24% | 0.01% | 3.98% (Jan 2025) | 0% (Nov 2024) | 5.45 L | 0.00 |
| Emcure Pharmaceuticals Ltd. | Pharmaceuticals | 108.2 | 3.22% | -0.04% | 3.45% (Aug 2025) | 0% (Nov 2024) | 82.00 k | 0.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 4.38% |
| MF Units | MF Units | 1.49% |
| Net Receivables | Net Receivables | -1.68% |
Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)
No data available. Ratios are only available for the funds which are 3 years old.
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Regular Plan - Growth | NA | 421.51 | -0.68 | 13.33 | 46.96 | 49.87 | 34.49 |
| Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth | NA | 273.51 | 1.05 | 5.22 | 16.43 | 30.03 | 15.28 |
| Franklin Asian Equity Fund - Growth | NA | 297.12 | -2.01 | 8.13 | 18.10 | 22.78 | 11.16 |
| Quant BFSI Fund - Regular Plan - Growth | NA | 680.73 | 3.22 | 9.70 | 15.09 | 21.53 | 0.00 |
| HDFC Transportation and Logistics Fund - Regular Plan - Growth | NA | 1733.63 | -0.01 | 3.68 | 20.91 | 20.00 | 0.00 |
| DSP Banking & Financial Services Fund - Regular Plan - Growth | NA | 1518.73 | 2.46 | 9.89 | 7.29 | 18.88 | 0.00 |
| ITI Banking and Financial Services Fund - Regular Plan - Growth | NA | 333.18 | 3.50 | 11.90 | 9.45 | 18.86 | 13.32 |
| SBI Banking & Financial Services Fund - Regular Plan - Growth | NA | 9273.44 | 3.34 | 10.03 | 10.65 | 17.99 | 19.38 |
| UTI Transportation and Logistics Fund - Growth | NA | 4008.33 | 1.95 | 6.02 | 17.89 | 17.82 | 24.42 |
| Nippon India Japan Equity Fund - Growth | NA | 292.35 | -1.13 | 2.42 | 9.11 | 17.44 | 15.10 |
Out of 23 mutual fund schemes offered by this AMC, 2 is/are ranked 4 * , 1 is/are ranked 3 * , and 20 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Bajaj Finserv Money Market Fund - Regular Plan - Growth | 4 | 6101.32 | 0.47 | 1.37 | 2.95 | 7.03 | 0.00 |
| Bajaj Finserv Flexi Cap Fund - Regular Plan - Growth | NA | 6034.03 | 0.32 | 4.65 | 6.61 | 6.44 | 0.00 |
| Bajaj Finserv Liquid Fund - Regular Plan - Growth | 4 | 5996.06 | 0.47 | 1.40 | 2.87 | 6.48 | 0.00 |
| Bajaj Finserv Large and Mid Cap Fund - Regular Plan - Growth | NA | 2245.16 | 1.55 | 4.85 | 4.95 | 4.66 | 0.00 |
| Bajaj Finserv Large Cap Fund - Regular Plan - Growth | NA | 1666.14 | 1.66 | 6.56 | 6.13 | 5.66 | 0.00 |
| Bajaj Finserv Small Cap Fund - Regular Plan - Growth | NA | 1512.36 | -2.72 | 1.97 | 0.00 | 0.00 | 0.00 |
| Bajaj Finserv Balanced Advantage - Regular Plan - Growth | NA | 1325.24 | 1.57 | 6.11 | 5.14 | 7.15 | 0.00 |
| Bajaj Finserv Multi Asset Allocation Fund - Regular Plan - Growth | NA | 1283.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Bajaj Finserv Multi Asset Allocation Fund - Regular Plan - Growth | NA | 1283.50 | 2.84 | 10.07 | 11.93 | 14.60 | 0.00 |
| Bajaj Finserv Arbitrage Fund - Regular Plan - Growth | 3 | 1256.94 | 0.53 | 1.37 | 2.78 | 6.03 | 0.00 |